These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1323578)

  • 1. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory.
    Gretch D; Lee W; Corey L
    J Clin Microbiol; 1992 Aug; 30(8):2145-9. PubMed ID: 1323578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.
    François M; Dubois F; Brand D; Bacq Y; Guerois C; Mouchet C; Tichet J; Goudeau A; Barin F
    J Clin Microbiol; 1993 May; 31(5):1189-93. PubMed ID: 7684749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
    Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
    J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
    Bååth L; Widell A; Nordenfelt E
    J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
    Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
    J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
    Marcellin P; Martinot-Peignoux M; Elias A; Branger M; Courtois F; Level R; Erlinger S; Benhamou JP
    J Infect Dis; 1994 Aug; 170(2):433-5. PubMed ID: 7518489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.
    Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C
    J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.
    de Medina M; Hill M; Sullivan HO; Leclerq B; Pennell JP; Jeffers L; Reddy KR; Schiff ER; Perez GO
    J Lab Clin Med; 1998 Jul; 132(1):73-5. PubMed ID: 9665375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hepatitis C virus kits.
    Chaudhary RK; Frenette S; Mo T
    J Clin Microbiol; 1991 Nov; 29(11):2616-7. PubMed ID: 1723074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
    Pawlotsky JM; Bastie A; Pellet C; Remire J; Darthuy F; Wolfe L; Sayada C; Duval J; Dhumeaux D
    J Clin Microbiol; 1996 Jan; 34(1):80-3. PubMed ID: 8748278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferase.
    Prince AM; Scheffel JW; Moore B
    Transfusion; 1997 Feb; 37(2):211-4. PubMed ID: 9051098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
    Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
    Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients.
    Bresters D; Zaaijer HL; Cuypers HT; Reesink HW; Winkel IN; van Exel-Oehlers PJ; van Drimmelen AA; Jansen PL; van der Poel CL; Lelie PN
    Transfusion; 1993 Aug; 33(8):634-8. PubMed ID: 7688158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
    Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
    Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the patients with low levels of anti-HCV positivity].
    Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
    Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatitis C virus infection with recombinant immunoblot assay, synthetic immunoblot assay, and polymerase chain reaction.
    Chaudhary RK; Andonov A; MacLean C
    J Clin Lab Anal; 1993; 7(3):164-7. PubMed ID: 7685380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.
    Gretch DR; dela Rosa C; Carithers RL; Willson RA; Williams B; Corey L
    Ann Intern Med; 1995 Sep; 123(5):321-9. PubMed ID: 7542853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
    Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
    Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.
    MacDonald KL; Mills WA; Wood RC; Hanson M; Kline W; Bowman RJ; Polesky HF; Williams AE; Osterholm MT
    Transfusion; 1994 Mar; 34(3):202-8. PubMed ID: 8146891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.